[go: up one dir, main page]

AR008064A1 - A LOW MOLECULAR WEIGHT TRUMPED TUMOR NECROSIS FACTOR BINDING PROTEIN (TNF BP), A POLYNUCLEOTIDE CODIFIER OF SUCH PROTEIN, A VECTOR, A HOSPED CELL, METHODS TO PRODUCE SUCH PROTEIN, A COMPOSITIONAL COMPOSITION BP AND USES OF SUCH PROTEIN. - Google Patents

A LOW MOLECULAR WEIGHT TRUMPED TUMOR NECROSIS FACTOR BINDING PROTEIN (TNF BP), A POLYNUCLEOTIDE CODIFIER OF SUCH PROTEIN, A VECTOR, A HOSPED CELL, METHODS TO PRODUCE SUCH PROTEIN, A COMPOSITIONAL COMPOSITION BP AND USES OF SUCH PROTEIN.

Info

Publication number
AR008064A1
AR008064A1 ARP970103052A ARP970103052A AR008064A1 AR 008064 A1 AR008064 A1 AR 008064A1 AR P970103052 A ARP970103052 A AR P970103052A AR P970103052 A ARP970103052 A AR P970103052A AR 008064 A1 AR008064 A1 AR 008064A1
Authority
AR
Argentina
Prior art keywords
protein
tumor necrosis
vector
polynucleotide
necrosis factor
Prior art date
Application number
ARP970103052A
Other languages
Spanish (es)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR008064A1 publication Critical patent/AR008064A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describen nuevas proteínas, llamadas proteínas ligantes del factor de necrosis tumoral, un polinucleótido codificante, un vector, una célulahospedante y una composición farmacéutica. También se describen los procesos para obtener lasproteín as que se ligan a la necrosis tumoral por técnicas deingeniería genética recombinante.Novel proteins are described, called tumor necrosis factor binding proteins, a coding polynucleotide, a vector, a host cell, and a pharmaceutical composition. The processes to obtain the proteins that are linked to tumor necrosis by recombinant genetic engineering techniques are also described.

ARP970103052A 1996-07-09 1997-07-08 A LOW MOLECULAR WEIGHT TRUMPED TUMOR NECROSIS FACTOR BINDING PROTEIN (TNF BP), A POLYNUCLEOTIDE CODIFIER OF SUCH PROTEIN, A VECTOR, A HOSPED CELL, METHODS TO PRODUCE SUCH PROTEIN, A COMPOSITIONAL COMPOSITION BP AND USES OF SUCH PROTEIN. AR008064A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2144396P 1996-07-09 1996-07-09
US3253496P 1996-12-06 1996-12-06
US3373797P 1997-01-23 1997-01-23
US3931497P 1997-02-07 1997-02-07

Publications (1)

Publication Number Publication Date
AR008064A1 true AR008064A1 (en) 1999-12-09

Family

ID=51929829

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103052A AR008064A1 (en) 1996-07-09 1997-07-08 A LOW MOLECULAR WEIGHT TRUMPED TUMOR NECROSIS FACTOR BINDING PROTEIN (TNF BP), A POLYNUCLEOTIDE CODIFIER OF SUCH PROTEIN, A VECTOR, A HOSPED CELL, METHODS TO PRODUCE SUCH PROTEIN, A COMPOSITIONAL COMPOSITION BP AND USES OF SUCH PROTEIN.

Country Status (1)

Country Link
AR (1) AR008064A1 (en)

Similar Documents

Publication Publication Date Title
ATE380866T1 (en) TNF RECEPTOR-ASSOCIATED FACTOR MODULATORS, THEIR PREPARATION AND USES
PT93910A (en) A product for the preparation of a blood protein by means of a blood cell
EP0653940A4 (en) GLOBAL MITOGENIC FACTORS, THEIR PREPARATION AND USE.
BR9710350A (en) Stnfr truncated tumor necrosis-binding protein and polyvalent polynucleotide nucleic acid sequence polynucleotide vector c-cell procardiotic host pharmaceutical composition processes for silvering a disease mediated by tnf e to prepare a pharmaceutical composition using the tumor necrosis factor binding protein and kit
NL300129I1 (en) TFN binding proteins.
DK0970213T3 (en) Death domain-containing receptor
ES8703490A1 (en) A PROCEDURE FOR PRODUCING A POLYPEPTIDE THAT HAS OR CONTAINS A HUMAN TUMOR NECROSIS FACTOR POLYPEPTIDE
DE69022559D1 (en) Expression of the recombinant tumor necrosis factor binding protein I (TBP-I).
CY1112101T1 (en) Neurotrophic factors
ES8705521A1 (en) A METHOD OF PRODUCING A TUMOR NECROSIS FACTOR (TNF) SIMILAR FROM MAMMALS.
WO2002068605A3 (en) Non-oligomerizing tandem fluorescent proteins
DK0604418T3 (en) Isolated viral protein cytokine antagonists
WO2000066156A8 (en) Death domain containing receptor 5
AU1172202A (en) Far red shifted fluorescent proteins
DE60235985D1 (en) NTB-A, A SURFACE MOLECULE IMPLIED IN THE ACTIVITY OF NATURAL KILLER CELLS (NK)
DK1255829T3 (en) Hepatocyte growth factor activator inhibitor for use in modulating angiogenesis and cardiovascularization
AR008064A1 (en) A LOW MOLECULAR WEIGHT TRUMPED TUMOR NECROSIS FACTOR BINDING PROTEIN (TNF BP), A POLYNUCLEOTIDE CODIFIER OF SUCH PROTEIN, A VECTOR, A HOSPED CELL, METHODS TO PRODUCE SUCH PROTEIN, A COMPOSITIONAL COMPOSITION BP AND USES OF SUCH PROTEIN.
EA200100395A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DNA FRAGMENTS ENCODING ANTIGENIC PROTEIN COATING ANTI-ANTITROTHAL EFFECT
ATE171217T1 (en) METHODS FOR SYNTHESIS AND PURIFICATION OF PEPTIDES
DE59913079D1 (en) RECOMBINANT MISTLE LEMONS
RU95101019A (en) Method of preparing tumor necrosis factor, tumor necrosis factor, dna, cell, composition
ES553374A0 (en) A PROCEDURE TO IMPROVE THE PRODUCTION OF A DESIRED POLYPEPTIDE IN A HOSPEDANTE TRANSFORMED WITH A RECOMBINANT DNA MOLECULA.
DK1233980T3 (en) A nucleic acid molecule comprising a nucleic acid sequence encoding a hemocyanin and at least one intron sequence
AR028828A1 (en) NUCLEIC AND POLYPEPTIDE ACIDS OF THE FITIL / PRENILTRANSFERASA, AND USES OF THE SAME
ATE93893T1 (en) EXPRESSION SYSTEMS FOR OVERPRODUCTION OF DESIRED PROTEINS.

Legal Events

Date Code Title Description
FB Suspension of granting procedure